GGrantIndex
← Search

NUCLEAR ERBB3 PREDICTS SENSITIVITY TO ANDROGEN RECEPTOR INHIBITORS IN CASTRATION-RESISTANT PROSTATE CANCER

$471,000FY2021Defense Health AgencyDOD

University Of California, Davis

Investigators

View source on USAspending →
NUCLEAR ERBB3 PREDICTS SENSITIVITY TO ANDROGEN RECEPTOR INHIBITORS IN CASTRATION-RESISTANT PROSTATE CANCER · GrantIndex